JOE A. MCCANN - 29 Nov 2022 Form 4 Insider Report for POINT Biopharma Global Inc. (PNT)

Role: Chief Executive Officer, Director
Signature: /s/ William L. Demers, by Power of Attorney for Joe A. McCann
Issuer symbol: PNT
Transactions as of: 29 Nov 2022
Net transactions value: +$14,342
Form type: 4
Filing time: 30 Nov 2022, 18:56:59 UTC
Previous filing: 31 Mar 2022
Next filing: 30 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PNT	Common Stock	Purchase	$14,342	+2,160	+0.06%	$6.64	3,616,313	29 Nov 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.639 to $6.640, inclusive. The Reporting Person undertakes to provide to POINT Biopharma Global Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.639 to $6.640, inclusive. The Reporting Person undertakes to provide to POINT Biopharma Global Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.